Africa (WHO region) vs Sri Lanka: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Sri Lanka
100.0%
in 2024
Africa (WHO region) rank
2nd
Sri Lanka rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Sri Lanka
How they compare
Sri Lanka currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 6 times across 18 shared years of data; in 2003 it was Sri Lanka ahead.
Africa (WHO region) ranks 2nd and Sri Lanka ranks 1st of 11 groups.
Across the 3 decades both report, Africa (WHO region) averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Africa (WHO region) | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.3% | 83.3% | 55.0% | Sri Lanka |
| 2010s | 74.3% | 81.1% | 6.8% | Sri Lanka |
| 2020s | 93.2% | 67.0% | 26.2% | Africa (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Sri Lanka?
- Sri Lanka, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Sri Lanka?
- 4.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Africa (WHO region) and Sri Lanka?
- 18 years are reported by both, from 2003 to 2024.
- How do Africa (WHO region) and Sri Lanka rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Sri Lanka ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.